Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: Ranbaxy (UK) Limited, 5<sup>th</sup> floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UB3 4AZ, United Kingdom
Loratadine 10 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. White to off-white, round, uncoated tablets debossed with “R” on one side and “10” on the other. |
Each tablet contains 10 mg loratadine.
Excipients with known effect: Each tablet also contains 78.25mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Loratadine |
Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Blister strip comprising of clear transparent PVC film (coated uniformly with PVdC on the inner side) with a backing of aluminium foil (coated with heat seal lacquer).
7, 10, 14, 20, 21, 30, and 100 tablets per pack.
Not all pack sizes are marketed.
Ranbaxy (UK) Limited, 5th floor, Hyde Park, Hayes 3, 11 Millington Road, Hayes, UB3 4AZ, United Kingdom
PL 14894/0112
19/09/2003 / 18/09/2008
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
